Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

Completed · Phase 4

Conditions studied: Healthy

In brief

This study is intended to evaluate whether intravenous (iv) esomeprazole (Nexium® ) offers better intragastric acid suppression than iv lansoprazole (Prevacid ®

Key facts

Study ID

NCT00230516

Run by

AstraZeneca

People needed

100

Starts

2005-09-01

Expected to finish

2006-02-01

Last updated by the study team

2013-01-04

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants must be 18-70 years of age
• Participants can be male or female
• Women that are able to have children must have a negative pregnancy test.

You may not qualify if…

• Involvement in or planning of this study
• Participation in another clinical study within 28 days of this one
• For women, pregnancy or attempting to become pregnant.

Where it is running

• Research Site — Los Angeles, California, United States
• Research Site — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.